This morning, we got the news that Operation Warp Speed is awarding $1.6 billion to Novavax for its COVID-19 vaccine. … This is the largest award that Operation Warp Speed has made yet for a vaccine, with the goal of potentially having 100 million doses available by the end of this year. How confident are you in being able to meet that goal? Well, everybody’s working toward that goal. We’ve started in early January when the gene sequence was first identified for coronavirus and we’ve been using a manufacturing platform that we’ve used on a lot of our vaccines over the past years to scale up, and we think we have the capability of doing that.
Novavax CEO on $1.6 Billion in Federal Funding for COVID-19 Vaccine Research
Published July 13, 2020 | Best in Video